News

For the first time, Vaping has been linked to new diagnoses of chronic obstructive pulmonary disease (COPD) which is an ...
The single-inhaler demonstrated a meaningful improvement in lung function in the Phase III KALOS and LOGOS studies.
Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune ...
This year’s “State of the Air” Report found that ground-level ozone pollution is getting worse – strikingly worse. This ...
Inhaled corticosteroids use is common in bronchiectasis, even among patients who don’t meet guideline criteria for ICS use.
Sleep apnea often goes undetected, but it can have a serious impact on your health. Here are the top symptoms and risk ...
Pilot scheme targeting respiratory diseases with integrated Western and Chinese medicine treatments is now available at four ...
Increased perceived stress is linked to worsened respiratory symptoms and decreased quality of life in individuals with ...
GSK to present data from across its respiratory portfolio at 2025 ATS International Congress in San Francisco: London, UK Monday, May 5, 2025, 10:00 Hrs [IST] GSK plc announced da ...